Global Radiolabeling Services Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Radiolabeling Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Radiolabeling Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 C-14
1.2.3 H-3
1.2.4 I-125
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Radiolabeling Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmacokinetics and Pharmacodynamics
1.3.3 Medical
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Radiolabeling Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Radiolabeling Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Radiolabeling Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Radiolabeling Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 C-14 Market Size by Players
3.3.2 H-3 Market Size by Players
3.3.3 I-125 Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Radiolabeling Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Radiolabeling Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Radiolabeling Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Radiolabeling Services Market Size by Type (2020-2031)
6.4 North America Radiolabeling Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Radiolabeling Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Radiolabeling Services Market Size by Type (2020-2031)
7.4 Europe Radiolabeling Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Radiolabeling Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Radiolabeling Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Radiolabeling Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Radiolabeling Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Radiolabeling Services Market Size by Type (2020-2031)
9.4 Central and South America Radiolabeling Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Radiolabeling Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Radiolabeling Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Radiolabeling Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Radiolabeling Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Charles River
11.1.1 Charles River Corporation Information
11.1.2 Charles River Business Overview
11.1.3 Charles River Radiolabeling Services Product Features and Attributes
11.1.4 Charles River Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.1.5 Charles River Radiolabeling Services Revenue by Product in 2024
11.1.6 Charles River Radiolabeling Services Revenue by Application in 2024
11.1.7 Charles River Radiolabeling Services Revenue by Geographic Area in 2024
11.1.8 Charles River Radiolabeling Services SWOT Analysis
11.1.9 Charles River Recent Developments
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Corporation Information
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Radiolabeling Services Product Features and Attributes
11.2.4 Eurofins Scientific Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.2.5 Eurofins Scientific Radiolabeling Services Revenue by Product in 2024
11.2.6 Eurofins Scientific Radiolabeling Services Revenue by Application in 2024
11.2.7 Eurofins Scientific Radiolabeling Services Revenue by Geographic Area in 2024
11.2.8 Eurofins Scientific Radiolabeling Services SWOT Analysis
11.2.9 Eurofins Scientific Recent Developments
11.3 PerkinElmer
11.3.1 PerkinElmer Corporation Information
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Radiolabeling Services Product Features and Attributes
11.3.4 PerkinElmer Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.3.5 PerkinElmer Radiolabeling Services Revenue by Product in 2024
11.3.6 PerkinElmer Radiolabeling Services Revenue by Application in 2024
11.3.7 PerkinElmer Radiolabeling Services Revenue by Geographic Area in 2024
11.3.8 PerkinElmer Radiolabeling Services SWOT Analysis
11.3.9 PerkinElmer Recent Developments
11.4 Sekisui Medical
11.4.1 Sekisui Medical Corporation Information
11.4.2 Sekisui Medical Business Overview
11.4.3 Sekisui Medical Radiolabeling Services Product Features and Attributes
11.4.4 Sekisui Medical Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.4.5 Sekisui Medical Radiolabeling Services Revenue by Product in 2024
11.4.6 Sekisui Medical Radiolabeling Services Revenue by Application in 2024
11.4.7 Sekisui Medical Radiolabeling Services Revenue by Geographic Area in 2024
11.4.8 Sekisui Medical Radiolabeling Services SWOT Analysis
11.4.9 Sekisui Medical Recent Developments
11.5 Eckert & Ziegler
11.5.1 Eckert & Ziegler Corporation Information
11.5.2 Eckert & Ziegler Business Overview
11.5.3 Eckert & Ziegler Radiolabeling Services Product Features and Attributes
11.5.4 Eckert & Ziegler Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.5.5 Eckert & Ziegler Radiolabeling Services Revenue by Product in 2024
11.5.6 Eckert & Ziegler Radiolabeling Services Revenue by Application in 2024
11.5.7 Eckert & Ziegler Radiolabeling Services Revenue by Geographic Area in 2024
11.5.8 Eckert & Ziegler Radiolabeling Services SWOT Analysis
11.5.9 Eckert & Ziegler Recent Developments
11.6 Labcorp
11.6.1 Labcorp Corporation Information
11.6.2 Labcorp Business Overview
11.6.3 Labcorp Radiolabeling Services Product Features and Attributes
11.6.4 Labcorp Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.6.5 Labcorp Recent Developments
11.7 XenoTech (BioIVT)
11.7.1 XenoTech (BioIVT) Corporation Information
11.7.2 XenoTech (BioIVT) Business Overview
11.7.3 XenoTech (BioIVT) Radiolabeling Services Product Features and Attributes
11.7.4 XenoTech (BioIVT) Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.7.5 XenoTech (BioIVT) Recent Developments
11.8 Quotient Sciences
11.8.1 Quotient Sciences Corporation Information
11.8.2 Quotient Sciences Business Overview
11.8.3 Quotient Sciences Radiolabeling Services Product Features and Attributes
11.8.4 Quotient Sciences Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.8.5 Quotient Sciences Recent Developments
11.9 Gifford Bioscience
11.9.1 Gifford Bioscience Corporation Information
11.9.2 Gifford Bioscience Business Overview
11.9.3 Gifford Bioscience Radiolabeling Services Product Features and Attributes
11.9.4 Gifford Bioscience Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.9.5 Gifford Bioscience Recent Developments
11.10 ITM Radiopharma
11.10.1 ITM Radiopharma Corporation Information
11.10.2 ITM Radiopharma Business Overview
11.10.3 ITM Radiopharma Radiolabeling Services Product Features and Attributes
11.10.4 ITM Radiopharma Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Almac Group
11.11.1 Almac Group Corporation Information
11.11.2 Almac Group Business Overview
11.11.3 Almac Group Radiolabeling Services Product Features and Attributes
11.11.4 Almac Group Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.11.5 Almac Group Recent Developments
11.12 Accelera
11.12.1 Accelera Corporation Information
11.12.2 Accelera Business Overview
11.12.3 Accelera Radiolabeling Services Product Features and Attributes
11.12.4 Accelera Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.12.5 Accelera Recent Developments
11.13 Novandi Chemistry
11.13.1 Novandi Chemistry Corporation Information
11.13.2 Novandi Chemistry Business Overview
11.13.3 Novandi Chemistry Radiolabeling Services Product Features and Attributes
11.13.4 Novandi Chemistry Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.13.5 Novandi Chemistry Recent Developments
11.14 AptoChem
11.14.1 AptoChem Corporation Information
11.14.2 AptoChem Business Overview
11.14.3 AptoChem Radiolabeling Services Product Features and Attributes
11.14.4 AptoChem Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.14.5 AptoChem Recent Developments
11.15 HMR
11.15.1 HMR Corporation Information
11.15.2 HMR Business Overview
11.15.3 HMR Radiolabeling Services Product Features and Attributes
11.15.4 HMR Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.15.5 HMR Recent Developments
11.16 AM Chemicals
11.16.1 AM Chemicals Corporation Information
11.16.2 AM Chemicals Business Overview
11.16.3 AM Chemicals Radiolabeling Services Product Features and Attributes
11.16.4 AM Chemicals Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.16.5 AM Chemicals Recent Developments
11.17 PolyPeptide Group
11.17.1 PolyPeptide Group Corporation Information
11.17.2 PolyPeptide Group Business Overview
11.17.3 PolyPeptide Group Radiolabeling Services Product Features and Attributes
11.17.4 PolyPeptide Group Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.17.5 PolyPeptide Group Recent Developments
11.18 NovoPro Bioscience
11.18.1 NovoPro Bioscience Corporation Information
11.18.2 NovoPro Bioscience Business Overview
11.18.3 NovoPro Bioscience Radiolabeling Services Product Features and Attributes
11.18.4 NovoPro Bioscience Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.18.5 NovoPro Bioscience Recent Developments
11.19 Institute of Isotopes
11.19.1 Institute of Isotopes Corporation Information
11.19.2 Institute of Isotopes Business Overview
11.19.3 Institute of Isotopes Radiolabeling Services Product Features and Attributes
11.19.4 Institute of Isotopes Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.19.5 Institute of Isotopes Recent Developments
11.20 Nuvisan
11.20.1 Nuvisan Corporation Information
11.20.2 Nuvisan Business Overview
11.20.3 Nuvisan Radiolabeling Services Product Features and Attributes
11.20.4 Nuvisan Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.20.5 Nuvisan Recent Developments
11.21 Revvity
11.21.1 Revvity Corporation Information
11.21.2 Revvity Business Overview
11.21.3 Revvity Radiolabeling Services Product Features and Attributes
11.21.4 Revvity Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.21.5 Revvity Recent Developments
11.22 Necsa
11.22.1 Necsa Corporation Information
11.22.2 Necsa Business Overview
11.22.3 Necsa Radiolabeling Services Product Features and Attributes
11.22.4 Necsa Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.22.5 Necsa Recent Developments
11.23 Fluorizon
11.23.1 Fluorizon Corporation Information
11.23.2 Fluorizon Business Overview
11.23.3 Fluorizon Radiolabeling Services Product Features and Attributes
11.23.4 Fluorizon Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.23.5 Fluorizon Recent Developments
11.24 Edinburgh Pharmaceutical Processes
11.24.1 Edinburgh Pharmaceutical Processes Corporation Information
11.24.2 Edinburgh Pharmaceutical Processes Business Overview
11.24.3 Edinburgh Pharmaceutical Processes Radiolabeling Services Product Features and Attributes
11.24.4 Edinburgh Pharmaceutical Processes Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.24.5 Edinburgh Pharmaceutical Processes Recent Developments
11.25 Pharmaron
11.25.1 Pharmaron Corporation Information
11.25.2 Pharmaron Business Overview
11.25.3 Pharmaron Radiolabeling Services Product Features and Attributes
11.25.4 Pharmaron Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.25.5 Pharmaron Recent Developments
11.26 Medicilon
11.26.1 Medicilon Corporation Information
11.26.2 Medicilon Business Overview
11.26.3 Medicilon Radiolabeling Services Product Features and Attributes
11.26.4 Medicilon Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.26.5 Medicilon Recent Developments
11.27 JOINN Laboratories
11.27.1 JOINN Laboratories Corporation Information
11.27.2 JOINN Laboratories Business Overview
11.27.3 JOINN Laboratories Radiolabeling Services Product Features and Attributes
11.27.4 JOINN Laboratories Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.27.5 JOINN Laboratories Recent Developments
11.28 Frontage
11.28.1 Frontage Corporation Information
11.28.2 Frontage Business Overview
11.28.3 Frontage Radiolabeling Services Product Features and Attributes
11.28.4 Frontage Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.28.5 Frontage Recent Developments
11.29 Abace Biotechnology
11.29.1 Abace Biotechnology Corporation Information
11.29.2 Abace Biotechnology Business Overview
11.29.3 Abace Biotechnology Radiolabeling Services Product Features and Attributes
11.29.4 Abace Biotechnology Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.29.5 Abace Biotechnology Recent Developments
11.30 Beijing Atom High-Tech
11.30.1 Beijing Atom High-Tech Corporation Information
11.30.2 Beijing Atom High-Tech Business Overview
11.30.3 Beijing Atom High-Tech Radiolabeling Services Product Features and Attributes
11.30.4 Beijing Atom High-Tech Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.30.5 Beijing Atom High-Tech Recent Developments
11.31 Wuxi Beita Pharmatech
11.31.1 Wuxi Beita Pharmatech Corporation Information
11.31.2 Wuxi Beita Pharmatech Business Overview
11.31.3 Wuxi Beita Pharmatech Radiolabeling Services Product Features and Attributes
11.31.4 Wuxi Beita Pharmatech Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.31.5 Wuxi Beita Pharmatech Recent Developments
11.32 Beijing North Institute of Biotechnology
11.32.1 Beijing North Institute of Biotechnology Corporation Information
11.32.2 Beijing North Institute of Biotechnology Business Overview
11.32.3 Beijing North Institute of Biotechnology Radiolabeling Services Product Features and Attributes
11.32.4 Beijing North Institute of Biotechnology Radiolabeling Services Revenue and Gross Margin (2020-2025)
11.32.5 Beijing North Institute of Biotechnology Recent Developments
12 Radiolabeling ServicesIndustry Chain Analysis
12.1 Radiolabeling Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Radiolabeling Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Radiolabeling Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Radiolabeling Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Radiolabeling Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Radiolabeling Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Radiolabeling Services Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Radiolabeling Services Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Radiolabeling Services Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Radiolabeling Services Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Radiolabeling Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiolabeling Services as of 2024)
Table 11. Global Radiolabeling Services Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Radiolabeling Services Companies Headquarters
Table 13. Global Radiolabeling Services Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Radiolabeling Services Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Radiolabeling Services Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Radiolabeling Services Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Radiolabeling Services Revenue by Application (2026-2031) & (US$ Million)
Table 21. Radiolabeling Services High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Radiolabeling Services Growth Accelerators and Market Barriers
Table 25. North America Radiolabeling Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Radiolabeling Services Growth Accelerators and Market Barriers
Table 27. Europe Radiolabeling Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Radiolabeling Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Radiolabeling Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Radiolabeling Services Investment Opportunities and Key Challenges
Table 31. Central and South America Radiolabeling Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Radiolabeling Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Radiolabeling Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Charles River Corporation Information
Table 35. Charles River Description and Major Businesses
Table 36. Charles River Product Features and Attributes
Table 37. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Charles River Revenue Proportion by Product in 2024
Table 39. Charles River Revenue Proportion by Application in 2024
Table 40. Charles River Revenue Proportion by Geographic Area in 2024
Table 41. Charles River Radiolabeling Services SWOT Analysis
Table 42. Charles River Recent Developments
Table 43. Eurofins Scientific Corporation Information
Table 44. Eurofins Scientific Description and Major Businesses
Table 45. Eurofins Scientific Product Features and Attributes
Table 46. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Eurofins Scientific Revenue Proportion by Product in 2024
Table 48. Eurofins Scientific Revenue Proportion by Application in 2024
Table 49. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
Table 50. Eurofins Scientific Radiolabeling Services SWOT Analysis
Table 51. Eurofins Scientific Recent Developments
Table 52. PerkinElmer Corporation Information
Table 53. PerkinElmer Description and Major Businesses
Table 54. PerkinElmer Product Features and Attributes
Table 55. PerkinElmer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. PerkinElmer Revenue Proportion by Product in 2024
Table 57. PerkinElmer Revenue Proportion by Application in 2024
Table 58. PerkinElmer Revenue Proportion by Geographic Area in 2024
Table 59. PerkinElmer Radiolabeling Services SWOT Analysis
Table 60. PerkinElmer Recent Developments
Table 61. Sekisui Medical Corporation Information
Table 62. Sekisui Medical Description and Major Businesses
Table 63. Sekisui Medical Product Features and Attributes
Table 64. Sekisui Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Sekisui Medical Revenue Proportion by Product in 2024
Table 66. Sekisui Medical Revenue Proportion by Application in 2024
Table 67. Sekisui Medical Revenue Proportion by Geographic Area in 2024
Table 68. Sekisui Medical Radiolabeling Services SWOT Analysis
Table 69. Sekisui Medical Recent Developments
Table 70. Eckert & Ziegler Corporation Information
Table 71. Eckert & Ziegler Description and Major Businesses
Table 72. Eckert & Ziegler Product Features and Attributes
Table 73. Eckert & Ziegler Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Eckert & Ziegler Revenue Proportion by Product in 2024
Table 75. Eckert & Ziegler Revenue Proportion by Application in 2024
Table 76. Eckert & Ziegler Revenue Proportion by Geographic Area in 2024
Table 77. Eckert & Ziegler Radiolabeling Services SWOT Analysis
Table 78. Eckert & Ziegler Recent Developments
Table 79. Labcorp Corporation Information
Table 80. Labcorp Description and Major Businesses
Table 81. Labcorp Product Features and Attributes
Table 82. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Labcorp Recent Developments
Table 84. XenoTech (BioIVT) Corporation Information
Table 85. XenoTech (BioIVT) Description and Major Businesses
Table 86. XenoTech (BioIVT) Product Features and Attributes
Table 87. XenoTech (BioIVT) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. XenoTech (BioIVT) Recent Developments
Table 89. Quotient Sciences Corporation Information
Table 90. Quotient Sciences Description and Major Businesses
Table 91. Quotient Sciences Product Features and Attributes
Table 92. Quotient Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Quotient Sciences Recent Developments
Table 94. Gifford Bioscience Corporation Information
Table 95. Gifford Bioscience Description and Major Businesses
Table 96. Gifford Bioscience Product Features and Attributes
Table 97. Gifford Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Gifford Bioscience Recent Developments
Table 99. ITM Radiopharma Corporation Information
Table 100. ITM Radiopharma Description and Major Businesses
Table 101. ITM Radiopharma Product Features and Attributes
Table 102. ITM Radiopharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. ITM Radiopharma Recent Developments
Table 104. Almac Group Corporation Information
Table 105. Almac Group Description and Major Businesses
Table 106. Almac Group Product Features and Attributes
Table 107. Almac Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Almac Group Recent Developments
Table 109. Accelera Corporation Information
Table 110. Accelera Description and Major Businesses
Table 111. Accelera Product Features and Attributes
Table 112. Accelera Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Accelera Recent Developments
Table 114. Novandi Chemistry Corporation Information
Table 115. Novandi Chemistry Description and Major Businesses
Table 116. Novandi Chemistry Product Features and Attributes
Table 117. Novandi Chemistry Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Novandi Chemistry Recent Developments
Table 119. AptoChem Corporation Information
Table 120. AptoChem Description and Major Businesses
Table 121. AptoChem Product Features and Attributes
Table 122. AptoChem Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. AptoChem Recent Developments
Table 124. HMR Corporation Information
Table 125. HMR Description and Major Businesses
Table 126. HMR Product Features and Attributes
Table 127. HMR Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. HMR Recent Developments
Table 129. AM Chemicals Corporation Information
Table 130. AM Chemicals Description and Major Businesses
Table 131. AM Chemicals Product Features and Attributes
Table 132. AM Chemicals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. AM Chemicals Recent Developments
Table 134. PolyPeptide Group Corporation Information
Table 135. PolyPeptide Group Description and Major Businesses
Table 136. PolyPeptide Group Product Features and Attributes
Table 137. PolyPeptide Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. PolyPeptide Group Recent Developments
Table 139. NovoPro Bioscience Corporation Information
Table 140. NovoPro Bioscience Description and Major Businesses
Table 141. NovoPro Bioscience Product Features and Attributes
Table 142. NovoPro Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. NovoPro Bioscience Recent Developments
Table 144. Institute of Isotopes Corporation Information
Table 145. Institute of Isotopes Description and Major Businesses
Table 146. Institute of Isotopes Product Features and Attributes
Table 147. Institute of Isotopes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. Institute of Isotopes Recent Developments
Table 149. Nuvisan Corporation Information
Table 150. Nuvisan Description and Major Businesses
Table 151. Nuvisan Product Features and Attributes
Table 152. Nuvisan Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. Nuvisan Recent Developments
Table 154. Revvity Corporation Information
Table 155. Revvity Description and Major Businesses
Table 156. Revvity Product Features and Attributes
Table 157. Revvity Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. Revvity Recent Developments
Table 159. Necsa Corporation Information
Table 160. Necsa Description and Major Businesses
Table 161. Necsa Product Features and Attributes
Table 162. Necsa Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. Necsa Recent Developments
Table 164. Fluorizon Corporation Information
Table 165. Fluorizon Description and Major Businesses
Table 166. Fluorizon Product Features and Attributes
Table 167. Fluorizon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 168. Fluorizon Recent Developments
Table 169. Edinburgh Pharmaceutical Processes Corporation Information
Table 170. Edinburgh Pharmaceutical Processes Description and Major Businesses
Table 171. Edinburgh Pharmaceutical Processes Product Features and Attributes
Table 172. Edinburgh Pharmaceutical Processes Revenue (US$ Million) and Gross Margin (2020-2025)
Table 173. Edinburgh Pharmaceutical Processes Recent Developments
Table 174. Pharmaron Corporation Information
Table 175. Pharmaron Description and Major Businesses
Table 176. Pharmaron Product Features and Attributes
Table 177. Pharmaron Revenue (US$ Million) and Gross Margin (2020-2025)
Table 178. Pharmaron Recent Developments
Table 179. Medicilon Corporation Information
Table 180. Medicilon Description and Major Businesses
Table 181. Medicilon Product Features and Attributes
Table 182. Medicilon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. Medicilon Recent Developments
Table 184. JOINN Laboratories Corporation Information
Table 185. JOINN Laboratories Description and Major Businesses
Table 186. JOINN Laboratories Product Features and Attributes
Table 187. JOINN Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 188. JOINN Laboratories Recent Developments
Table 189. Frontage Corporation Information
Table 190. Frontage Description and Major Businesses
Table 191. Frontage Product Features and Attributes
Table 192. Frontage Revenue (US$ Million) and Gross Margin (2020-2025)
Table 193. Frontage Recent Developments
Table 194. Abace Biotechnology Corporation Information
Table 195. Abace Biotechnology Description and Major Businesses
Table 196. Abace Biotechnology Product Features and Attributes
Table 197. Abace Biotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 198. Abace Biotechnology Recent Developments
Table 199. Beijing Atom High-Tech Corporation Information
Table 200. Beijing Atom High-Tech Description and Major Businesses
Table 201. Beijing Atom High-Tech Product Features and Attributes
Table 202. Beijing Atom High-Tech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 203. Beijing Atom High-Tech Recent Developments
Table 204. Wuxi Beita Pharmatech Corporation Information
Table 205. Wuxi Beita Pharmatech Description and Major Businesses
Table 206. Wuxi Beita Pharmatech Product Features and Attributes
Table 207. Wuxi Beita Pharmatech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 208. Wuxi Beita Pharmatech Recent Developments
Table 209. Beijing North Institute of Biotechnology Corporation Information
Table 210. Beijing North Institute of Biotechnology Description and Major Businesses
Table 211. Beijing North Institute of Biotechnology Product Features and Attributes
Table 212. Beijing North Institute of Biotechnology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 213. Beijing North Institute of Biotechnology Recent Developments
Table 214. Raw Materials Key Suppliers
Table 215. Distributors List
Table 216. Market Trends and Market Evolution
Table 217. Market Drivers and Opportunities
Table 218. Market Challenges, Risks, and Restraints
Table 219. Research Programs/Design for This Report
Table 220. Key Data Information from Secondary Sources
Table 221. Key Data Information from Primary Sources


List of Figures
Figure 1. Radiolabeling Services Product Picture
Figure 2. Global Radiolabeling Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. C-14 Product Picture
Figure 4. H-3 Product Picture
Figure 5. I-125 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Radiolabeling Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Pharmacokinetics and Pharmacodynamics
Figure 9. Medical
Figure 10. Others
Figure 11. Radiolabeling Services Report Years Considered
Figure 12. Global Radiolabeling Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 14. Global Radiolabeling Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Radiolabeling Services Revenue Market Share by Region (2020-2031)
Figure 16. Global Radiolabeling Services Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. C-14 Revenue Market Share by Player in 2024
Figure 19. H-3 Revenue Market Share by Player in 2024
Figure 20. I-125 Revenue Market Share by Player in 2024
Figure 21. Others Revenue Market Share by Player in 2024
Figure 22. Global Radiolabeling Services Revenue Market Share by Type (2020-2031)
Figure 23. Global Radiolabeling Services Revenue Market Share by Application (2020-2031)
Figure 24. North America Radiolabeling Services Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Radiolabeling Services Revenue (US$ Million) in 2024
Figure 26. North America Radiolabeling Services Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Radiolabeling Services Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Radiolabeling Services Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Radiolabeling Services Revenue (US$ Million) in 2024
Figure 33. Europe Radiolabeling Services Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Radiolabeling Services Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 36. France Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Radiolabeling Services Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Radiolabeling Services Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Radiolabeling Services Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Radiolabeling Services Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 48. India Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Radiolabeling Services Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Radiolabeling Services Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Radiolabeling Services Revenue (US$ Million) in 2024
Figure 56. Central and South America Radiolabeling Services Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Radiolabeling Services Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Radiolabeling Services Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Radiolabeling Services Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Radiolabeling Services Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Radiolabeling Services Revenue (US$ Million) in 2024
Figure 62. South America Radiolabeling Services Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Radiolabeling Services Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Radiolabeling Services Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Radiolabeling Services Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Radiolabeling Services Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Radiolabeling Services Revenue (2020-2025) & (US$ Million)
Figure 68. Radiolabeling Services Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit